Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C

M J Alter1, E E Mast, L A Moyer

  • 1Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Infectious Disease Clinics of North America
|March 12, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing ultrastable lasers at 7 × 10<sup>-17</sup> fractional frequency instability through a 2220 km optical fibre network.

Nature communications·2022
Same author

Test of Special Relativity Using a Fiber Network of Optical Clocks.

Physical review letters·2017
Same author

Frequency Comparison of [Formula: see text] Ion Optical Clocks at PTB and NPL via GPS PPP.

IEEE transactions on ultrasonics, ferroelectrics, and frequency control·2016
Same author

Transportable cavity-stabilized laser system for optical carrier frequency transmission experiments.

Applied optics·2015
Same author

Frequency ratio of two optical clock transitions in 171Yb+ and constraints on the time variation of fundamental constants.

Physical review letters·2014
Same author

Under-recognition and reporting of dengue in Cambodia: a capture-recapture analysis of the National Dengue Surveillance System.

Epidemiology and infection·2011
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Hepatitis C virus (HCV) causes chronic liver disease globally, with persistent infection often linked to weak immune responses. Injection drug use remains the primary driver of HCV transmission, yet public health efforts lag behind clinical advancements.

Area of Science:

  • Hepatology
  • Virology
  • Public Health

Background:

  • Hepatitis C virus (HCV) is a significant global cause of chronic liver disease.
  • Persistent HCV infection is common, often due to an inadequate neutralizing immune response.
  • Viral genetic diversity and host factors influence HCV's endemicity.

Purpose of the Study:

  • To highlight the factors contributing to the widespread prevalence of HCV infection.
  • To emphasize the critical role of injection drug use in HCV transmission.
  • To underscore the gap between clinical advancements and public health awareness/resource allocation for HCV.

Main Methods:

  • Review of epidemiological data on HCV transmission.
  • Analysis of factors influencing viral persistence and host immune response.

Related Experiment Videos

  • Assessment of public health strategies and resource allocation for HCV prevention and treatment.

    • Main Results:

    • Injection drug use is identified as the leading risk factor for HCV transmission in developed countries.
    • The majority of HCV infections become persistent, linked to immune evasion.
    • Despite clinical progress, public health awareness and resources for HCV remain insufficient.

    Conclusions:

    • Effective public health strategies must address injection drug use to curb HCV transmission.
    • Increased resources are crucial for comprehensive HCV prevention and treatment programs.
    • Bridging the gap between clinical knowledge and public health action is vital for controlling the HCV epidemic.